Robert J. Hariri - 11 Sep 2025 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Director
Signature
/s/Robert J. Hariri
Issuer symbol
CYRX
Transactions as of
11 Sep 2025
Net transactions value
-$109,738
Form type
4
Filing time
12 Sep 2025, 17:30:14 UTC
Previous filing
29 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hariri Robert J Director C/O CRYOPORT INC.112, WESTWOOD PLACE, SUITE 350, BRENTWOOD /s/Robert J. Hariri 12 Sep 2025 0001398815

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $133,000 +50,000 +190% $2.66 76,275 11 Sep 2025 Direct
transaction CYRX Common Stock Sale $242,738 -25,000 -33% $9.71 51,275 11 Sep 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Options Exercise $0 -50,000 -100% $0.000000 0 11 Sep 2025 Common Stock 50,000 $2.66 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.8609, inclusive.
F3 1/48 of the options vested on the 25th of each month for forty-eight months beginning on 9/25/2015.

Remarks:

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.